Peter D Haytaian's most recent trade in Elevance Health Inc was a trade of 11,549 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elevance Health | Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 11,549 | 11,549 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 4,213 | 26,004 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 3,035 | 21,791 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 395.50 per share. | 03 Mar 2025 | 2,281 | 18,756 (0%) | 0% | 395.5 | 902,136 | Common Stock |
| Elevance Health | Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 3,799 | 21,037 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 414.01 per share. | 01 Nov 2024 | 1,649 | 17,238 (0%) | 0% | 414.0 | 682,702 | Common Stock |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 166.97 per share. | 01 Mar 2024 | 15,000 | 39,982 (0%) | 0% | 167.0 | 2,504,550 | Common Stock |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 15,000 | 4,908 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Sale of securities on an exchange or to another person at price $ 500.18 per share. | 01 Mar 2024 | 15,000 | 18,887 (0%) | 0% | 500.2 | 7,502,700 | Common Stock |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 9,280 | 9,280 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 9,152 | 24,982 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 499.11 per share. | 01 Mar 2024 | 4,314 | 13,425 (0%) | 0% | 499.1 | 2,153,161 | Common Stock |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Sale of securities on an exchange or to another person at price $ 500.18 per share. | 01 Mar 2024 | 4,206 | 35,776 (0%) | 0% | 500.2 | 2,103,757 | Common Stock |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,405 | 15,830 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Sale of securities on an exchange or to another person at price $ 500.18 per share. | 01 Mar 2024 | 1,889 | 33,887 (0%) | 0% | 500.2 | 944,840 | Common Stock |